Skip to main content

Torrent Pharma Rating ‘Buy’; Firm has advantage on RM pressures

FY22/23/24e EPS down ~10-11%; TP reduced to Rs 3,202; upgraded to ‘Buy’ rating

from The Financial Express https://ift.tt/3CTrGgp
https://ift.tt/eA8V8J Nomura

Comments

Popular posts from this blog